{"id":"NCT00559468","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Sugammadex After Continuous Infusion of Rocuronium During Sevoflurane and Propofol Anesthesia (P05949; MK-8616-028)","officialTitle":"A Multi -Center, Randomized, Parallel Group, Safety Assessor Blinded Trial Comparing Efficacy and Safety of 4.0 mg.Kg-1 Sugammadex , Administered at T1 3-10% After Continuous Infusion of Rocuronium, and Pharmacokinetics of Rocuronium, Between Subjects Receiving Maintenance Anesthesia Using Propofol and Subjects Receiving Maintenance Anesthesia Using Sevoflurane","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-12-07","primaryCompletion":"2007-03-02","completion":"2007-03-02","firstPosted":"2007-11-16","resultsPosted":"2019-02-08","lastUpdate":"2019-11-25"},"enrollment":52,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Anesthesia, General"],"interventions":[{"type":"DRUG","name":"Sugammadex","otherNames":["Org 25969","MK-8616"]},{"type":"DRUG","name":"Rocuronium","otherNames":["Esmeron®","Rocuronium Bromide"]},{"type":"DRUG","name":"Sevoflurane","otherNames":["Ultane®"]},{"type":"DRUG","name":"Propofol","otherNames":["Diprivan®"]}],"arms":[{"label":"Sugammadex + Sevoflurane","type":"EXPERIMENTAL"},{"label":"Sugammadex + Propofol","type":"EXPERIMENTAL"}],"summary":"The objective of the trial was to show equivalence in recovery from neuromuscular block after a single dose of 4.0 mg/kg sugammadex, administered at first twitch (T1) 3-10% after continuous infusion of rocuronium, between participants receiving maintenance anesthesia using propofol and participants receiving sevoflurane, to investigate the safety and to compare the plasma levels of rocuronium in participants after continuous infusion of rocuronium and before the administration of sugammadex, under either propofol or sevoflurane anesthesia.","primaryOutcome":{"measure":"Mean Time From Start Administration of Sugammadex to Recovery of Fourth Twitch/First Twitch (T4/T1) Ratio to 0.9","timeFrame":"Up to 3 minutes after sugammadex administration","effectByArm":[{"arm":"Sugammadex + Sevoflurane","deltaMin":1.45,"sd":0.45},{"arm":"Sugammadex + Propofol","deltaMin":1.32,"sd":0.4}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":9},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["19512873"],"seeAlso":["http://www.merck.com/clinical-trials/policies-perspectives.html"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":26},"commonTop":["Procedural pain","Constipation","Nausea","Flatulence","Insomnia"]}}